Brigida Anna Maiorano (Brigida A Maiorano)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 27

Top Topics

Systematic Review

Metastatic Renal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

International journal of molecular sciences

Targeted oncology

BJOG : an international journal of obstetrics and gynaecology

This page only lists publications with an associated author ORCID identifier.

Publications

Brigida Anna Maiorano, Andrea Necchi, Massimo Di Maio
Author's Reply to Ma et al.: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis". Targeted oncology (2024)
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, Guido Giordano, Piergiorgio Di Tullio, Felicia Maria Maselli, Matteo Landriscina, Vincenza Conteduca
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer? Therapeutic advances in medical oncology 16 (2024)
Chiara Mercinelli, Marco Moschini, Antonio Cigliola, Benedetta Mattorre, Valentina Tateo, Giuseppe Basile, Laura L Cogrossi, Brigida Anna Maiorano, Damiano A Patanè, Daniele Raggi, Giovanni L Pastorino, Chiara Re, Maurizio Colecchia, Roberta Lucianò, Renzo Colombo, Giorgio Brembilla, Francesco De Cobelli, Alberto Briganti, Dean C Pavlick, Jeffery S Ross, Francesco Montorsi, Maria Teresa Sabrina Bertilaccio, Andrea Necchi
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mauro Francesco Pio Maiorano, Carlo Messina, Evaristo Maiello, Gennaro Cormio, Brigida Anna Maiorano
Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites? BJOG : an international journal of obstetrics and gynaecology (2024)
Brigida Anna Maiorano, Andrea Necchi, Massimo Di Maio
Author's Reply to Ma et al.: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis". Targeted oncology (2024)
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, Guido Giordano, Piergiorgio Di Tullio, Felicia Maria Maselli, Matteo Landriscina, Vincenza Conteduca
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer? Therapeutic advances in medical oncology 16 (2024)
Mauro Francesco Pio Maiorano, Carlo Messina, Evaristo Maiello, Gennaro Cormio, Brigida Anna Maiorano
Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites? BJOG : an international journal of obstetrics and gynaecology 131 (8) (2024)
Mauro Francesco Pio Maiorano, Carlo Messina, Evaristo Maiello, Gennaro Cormio, Brigida Anna Maiorano
Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites? BJOG : an international journal of obstetrics and gynaecology 131 (8) (2024)
Brigida Anna Maiorano, Ugo De Giorgi, Elena Verzoni, Evaristo Maiello, Giuseppe Procopio, Vincenza Conteduca, Massimo Di Maio, null null
Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis. Targeted oncology (2023)
Brigida Anna Maiorano, Ugo De Giorgi, Elena Verzoni, Evaristo Maiello, Giuseppe Procopio, Vincenza Conteduca, Massimo Di Maio, null null
Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis. Targeted oncology (2023)
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Melissa Bersanelli, Francesco Pierantoni, Ugo De Giorgi, Marilena Di Napoli, Roberto Iacovelli, Maria Giuseppa Vitale, Paola Ermacora, Andrea Malgeri, Brigida Anna Maiorano, Veronica Prati, Alessia Mennitto, Alessia Cavo, Matteo Santoni, Claudia Carella, Lucia Fratino, Giuseppe Procopio, Elena Verzoni, Daniele Santini
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a). International journal of molecular sciences 24 (2) (2023)
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Melissa Bersanelli, Francesco Pierantoni, Ugo De Giorgi, Marilena Di Napoli, Roberto Iacovelli, Maria Giuseppa Vitale, Paola Ermacora, Andrea Malgeri, Brigida Anna Maiorano, Veronica Prati, Alessia Mennitto, Alessia Cavo, Matteo Santoni, Claudia Carella, Lucia Fratino, Giuseppe Procopio, Elena Verzoni, Daniele Santini
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a). International journal of molecular sciences 24 (2) (2023)
Paola Parente, Stefano Ascani, Brigida Anna Maiorano, Magda Zanelli, Davide Ciardiello
Letter: be careful of gastrointestinal CMV infection in adverse events from ICIs therapy in solid tumours. Alimentary pharmacology & therapeutics 57 (8) (2023)
Mauro Francesco Pio Maiorano, Brigida Anna Maiorano, Annalucia Biancofiore, Gennaro Cormio, Evaristo Maiello
Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Melissa Bersanelli, Francesco Pierantoni, Ugo De Giorgi, Marilena Di Napoli, Roberto Iacovelli, Maria Giuseppa Vitale, Paola Ermacora, Andrea Malgeri, Brigida Anna Maiorano, Veronica Prati, Alessia Mennitto, Alessia Cavo, Matteo Santoni, Claudia Carella, Lucia Fratino, Giuseppe Procopio, Elena Verzoni, Daniele Santini
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a). International journal of molecular sciences 24 (2) (2023)
Brigida Anna Maiorano, Maria Concetta Fargnoli, Evaristo Maiello, Davide Ciardiello
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer. Life (Basel, Switzerland) 12 (10) (2022)
Brigida Anna Maiorano, Domenica Lorusso, Mauro Francesco Pio Maiorano, Davide Ciardiello, Paola Parrella, Antonio Petracca, Gennaro Cormio, Evaristo Maiello
The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy. International journal of molecular sciences 23 (7) (2022)
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Davide Ciardiello, Annamaria Maglione, Michele Orditura, Domenica Lorusso, Evaristo Maiello
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review. Cancers 14 (23) (2022)
Davide Ciardiello, Brigida Anna Maiorano, Paola Parente, Maria Grazia Rodriquenz, Tiziana Pia Latiano, Cinzia Chiarazzo, Valerio Pazienza, Luigi Pio Guerrera, Brunella Amoruso, Nicola Normanno, Giulia Martini, Fortunato Ciardiello, Erika Martinelli, Evaristo Maiello
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives. International journal of molecular sciences 23 (2) (2022)
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Davide Ciardiello, Annamaria Maglione, Michele Orditura, Domenica Lorusso, Evaristo Maiello
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review. Cancers 14 (23) (2022)
Brigida Anna Maiorano, Ugo De Giorgi, Davide Ciardiello, Giovanni Schinzari, Antonio Cisternino, Giampaolo Tortora, Evaristo Maiello
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day. Biomedicines 10 (2) (2022)
Paola Parente, Brigida Anna Maiorano, Davide Ciardiello, Francesco Cocomazzi, Sonia Carparelli, Maria Guerra, Giuseppe Ingravallo, Gerardo Cazzato, Illuminato Carosi, Evaristo Maiello, Fabrizio Bossa
Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience. Diagnostics (Basel, Switzerland) 12 (3) (2022)
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Davide Ciardiello, Annamaria Maglione, Michele Orditura, Domenica Lorusso, Evaristo Maiello
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review. Cancers 14 (23) (2022)
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, Massimo Di Maio, Evaristo Maiello
Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Alberto Bongiovanni, Brigida Anna Maiorano, Irene Azzali, Chiara Liverani, Martine Bocchini, Valentina Fausti, Giandomenico Di Menna, Ilaria Grassi, Maddalena Sansovini, Nada Riva, Toni Ibrahim
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, Evaristo Maiello
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives. Cancers 13 (17) (2021)
Brigida Anna Maiorano, Giovanni Schinzari, Davide Ciardiello, Maria Grazia Rodriquenz, Antonio Cisternino, Giampaolo Tortora, Evaristo Maiello
Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities. Vaccines 9 (6) (2021)